Kyverna Therapeutics, Inc. (KYTX)
$8.24-2.14%Close
BUYRECOVERY · day 13
Key stats
Short interest · FINRA settlement 2026-07-31
- Market cap
- $501M
- Avg volume
- 1.1M
- Beta
- 1.94
- P/E (TTM)
- -2.95
- Short % float
- 29.70%
- Days to cover
- 8.7
- SI change
- +4.2%
- 1W
- -7.93%
- 1M
- +11.20%
- 3M
- -4.96%
- YTD
- -6.04%
- vs SPY 1W
- -6.74%
- vs SPY 1M
- +7.88%
- vs SPY 3M
- -7.35%
- vs SPY YTD
- -17.80%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- TENXSELLTenax Therapeutics, Inc.CRISISQ -6$1.85+5.71%
- OFIXSELLOrthofix Medical Inc.CRISISQ 3$9.79-2.20%
- ACETBUYAdicet Bio, Inc.RECOVERYQ -27$8.90-3.16%
- LXEOBUYLexeo Therapeutics, Inc. Common StockRECOVERYQ -3$4.92+0.82%
- PVLASELLPalvella Therapeutics, Inc.BEARQ 14$145.75+2.61%
- ZJYLBUYJin Medical International Ltd.CRISISQ 4$3.04+0.00%
- RLMDSELLRelmada Therapeutics, Inc.CRISISQ 10$4.58-1.08%
- RCELBUYAVITA Medical, Inc.RECOVERYQ 4$9.91-1.49%
- MDCXSELLMedicus Pharma Ltd. Common StockCRISISQ -35$0.26-3.70%
- AVTRBUYAvantor, Inc.RECOVERYQ 2$14.26-1.38%
- AKTXSELLAkari Therapeutics, PlcRECOVERYQ -12$7.47-4.84%
- NVNOSELLenVVeno Medical CorporationCRISISQ -25$10.35+0.58%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 13
- VALUE
- 8
- GROWTH
- 45
- GARP
- 6
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-49.1%
REV YoY-
ROE-81.9%
EPS YoY-
ROA-69.4%
GROSS0
OP0
NET0
[VALUATION]
P/E TTM-2.95
P/E FWD-
SECTOR PE22.62
INDUSTRY PE17.13
P/B3.19
P/FCF-
EV/EBITDA-3.46
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E19.93
ALTMAN Z-
CURR RATIO9.06
ND/EBITDA-
BETA1.94
